Key result
Extended septal myectomy for HOCM yields ~98% 5-year survival with low in-hospital mortality.
Why the study?
Long-term outcome data with paired echocardiographic follow-up after septal myectomy for HOCM from the Indian subcontinent were limited.
Does extended septal myectomy improve long-term survival and clinical outcomes in patients with hypertrophic obstructive cardiomyopathy in an Asian cohort?
Cohort (n=399)
No
Does extended septal myectomy improve long-term survival and clinical outcomes in patients with hypertrophic obstructive cardiomyopathy in an Asian cohort?
Extended septal myectomy in an Asian cohort from the Indian subcontinent demonstrates low in-hospital mortality (1.5%) and high 5-year (98.1%) and 10-year (95.9%) survival rates, comparable to established global referral centers.
Answers are grounded in this paper and cite their sources.
Low mortality and high survival after myectomy in Asian HOCM; extends prior data but leaves open randomized comparisons.
BackgroundHypertrophic obstructive cardiomyopathy (HOCM) is a complex cardiac disorder often treated with septal myectomy, the gold-standard surgical intervention that improves symptoms and survival. Long-term outcome data with paired echocardiographic follow-up from the Indian subcontinent remain limited.MethodsThis was a retrospective cohort study of consecutive patients undergoing extended septal myectomy for HOCM at a single tertiary referral centre between 2014 and 2024, analysed from a prospectively maintained clinical registry. Demographic, clinical, echocardiographic, operative and follow-up data were analysed. Survival was estimated by the Kaplan-Meier method.ResultsA total of 399 patients underwent extended septal myectomy (mean age 41.2 ± 16.5 years; 282/399, 70.7% male; 46/399, 11.5% aged under 18 years). Septal hypertrophy was mainly mid-septal (255/399, 63.9%), with basal (110/399, 27.6%) and apical (34/399, 8.5%) involvement. Myectomy was isolated in 247/399 patients (61.9%) and combined with a concomitant procedure in 152/399 (38.1%); 15/399 patients (3.8%) had undergone a prior cardiac intervention, including alcohol septal ablation in 1/399 (0.3%) and previous cardiac surgery in 9/399 (2.3%). In-hospital mortality was 6/399 (1.5%). Mean follow-up was 5.4 ± 3.1 years, and median follow-up was 5.9 years (interquartile range 2.5-6.7); vital status was complete for all patients. Survival was 98.1% (95% CI 96.7-99.5) at 5 years and 95.9% (95% CI 92.7-99.0) at 10 years.ConclusionsExtended septal myectomy provides excellent structural, functional, and survival outcomes, comparable to leading centres. It should remain the preferred surgical treatment for symptomatic HOCM.
No takes yet. Share an insight, caveat, or question.
Shetty et al. (2026) conducted a cohort in Hypertrophic obstructive cardiomyopathy (n=399). Extended septal myectomy was evaluated on Survival at 5 and 10 years (95% CI 96.7-99.5). Extended septal myectomy for HOCM yielded 1.5% in-hospital mortality, with 5-year survival of 98.1% and 10-year survival of 95.9%.
Synapse has enriched 10 related papers. Consider them for comparative context: